Cytodyn Inc (CYDY)

[misiu143]

Yes , I agree 40% would be much better , but it is difficult to do when FDA sabotaged this study refusing to allow 4 treatments.

So for under-treated patient 31% mortality benefit at 28 days ABOVE all SOC drugs is very good , especially for these 31% as one may imagine ..

My son was very severely sick..Nothing they gave was working , he was on the critical list , and then leronlimab came , in 2 hrs he started to improve and 26 hrs after the first dose he was discharged home on oxygen.

Company send to the hospital 2 weeks treatment , but at 2 weeks he was much better but still at risk , having bilateral pneumonia and needed oxygen night a day.
We asked for another 2 treatment , our company kindly send it , and this 2 more doses visibly helped to save his life.
I am not sure if he will survive with 2 only,

Leronlimab is a miracle ..it was hard to believe the improvement from hr to hr , after these other approved , worthless drugs did nothing..

imo.